Novo Nordisk Expands UNICEF Partnership to Tackle Childhood Obesity in 7 Countries
Event summary
- Novo Nordisk commits $18 million from 2026 to 2030 to expand its partnership with UNICEF.
- The four-year program, running from 2027 to 2030, aims to support over 80 million children in Mexico, Colombia, Indonesia, the Philippines, India, Egypt, and Kenya.
- Childhood obesity has surpassed underweight globally for the first time, affecting 1 in 5 children aged 5 to 19.
- Interventions include growth monitoring, nutrition counseling, peer support, and legislation to promote healthier diets.
The big picture
Novo Nordisk's expanded partnership with UNICEF comes at a critical juncture as childhood obesity surpasses underweight globally. This initiative aligns with broader industry trends towards preventive healthcare and addresses a growing public health crisis, particularly in low- and middle-income countries. The $18 million commitment underscores Novo Nordisk's strategic focus on sustainability and long-term health outcomes beyond its core pharmaceutical business.
What we're watching
- Program Execution
- The pace at which Novo Nordisk and UNICEF can implement evidence-based policies and interventions in diverse geographies.
- Policy Impact
- Whether the partnership can effectively influence legislation to promote healthier diets and environments for children.
- Scalability
- How the model developed in existing countries can be adapted and expanded to new contexts.
Related topics